Immunovant (IMVT) Net Income (2018 - 2026)
Immunovant's Net Income came in at -$153.22 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$120.61 million a year earlier.
Powered by 
Analysis
Immunovant (IMVT) Net Income (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Immunovant reported Net Income of -$538.22 million; for FY2026 (ended Mar 31, 2026), it came in at -$505.61 million.
- Going back by fiscal year, Net Income was -$413.84 million in FY2025, -$259.34 million in FY2024, -$210.96 million in FY2023 and -$156.73 million in FY2022.
- The fiscal Q1 2027 figure represents the lowest quarterly Net Income in data going back to fiscal Q3 2019.
- Business Quant data shows IMVT's Net Income at -$147.86 million (Q4 2026), -$110.64 million (Q3 2026) and -$126.5 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.36 Bn | 1,112.95 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 635.36 Bn | 555.22 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 502.79 Bn | 475.90 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 356.08 Bn | 310.46 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 300.87 Bn | 264.86 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 264.31 Bn | 237.99 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 239.07 Bn | 194.47 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 194.50 Bn | 168.70 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Immunovant | 5.88 Bn | 2.66 Bn | - | -153.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -153.22 Mn |
| Mar 31, 2026 | -147.86 Mn |
| Dec 31, 2025 | -110.64 Mn |
| Sep 30, 2025 | -126.50 Mn |
| Jun 30, 2025 | -120.61 Mn |
| Mar 31, 2025 | -106.45 Mn |
| Dec 31, 2024 | -111.12 Mn |
| Sep 30, 2024 | -109.12 Mn |
| Jun 30, 2024 | -87.15 Mn |
| Mar 31, 2024 | -75.32 Mn |
| Dec 31, 2023 | -51.42 Mn |
| Sep 30, 2023 | -58.66 Mn |
| Jun 30, 2023 | -73.94 Mn |
| Mar 31, 2023 | -59.43 Mn |
| Dec 31, 2022 | -63.23 Mn |
| Sep 30, 2022 | -47.93 Mn |
| Jun 30, 2022 | -40.37 Mn |
| Mar 31, 2022 | -47.17 Mn |
| Dec 31, 2021 | -41.39 Mn |
| Sep 30, 2021 | -37.70 Mn |
API Access
Immunovant Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=IMVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "IMVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=IMVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();